Intel Shares Jump on Report of Talks With SK Hynix
episodeTranscript
jump: chapters · speakers · find in transcriptTranscript
Transcript generated automatically by AI and may contain errors.
What is the main topic discussed in this episode?
I'm Laura Thurow with Baird Private Wealth Management. You've been doing all the right things, saving, investing, building toward your goals. Healthcare can be a major expense today and an even greater one over time. Tools like long-term care insurance or a smart health savings account strategy can help protect what you've worked so hard to build. Learn more at BairdWealth.com slash WSJGuidebook.
Here's your midday brief for Wednesday, September 16th.
Why did Intel shares jump after reports of talks with SK Hynix?
I'm Alex Osola for The Wall Street Journal. Shares of Intel jumped following a report that the company's in talks with South Korea's SK Hynix to manufacture memory chips in the U.S. According to Reuters, the potential deal could involve leasing Intel's planned Ohio factory or forming a joint venture along with cloud computing firms to lock in chip supply.
What are the details of the potential Intel‑SK Hynix memory‑chip partnership?
Any deal could face opposition from the South Korean government. An Intel spokesperson said the company doesn't comment on speculation. SK Hynix said it's, quote, exploring various options, but that no specific plans have been finalized.
How did U.S. retail sales perform in August and why did they rebound?
Intel shares were up more than 4 percent by late morning. U.S.
How are Novo Nordisk and Anthropic using Claude AI to speed drug discovery?
retail sales rebounded last month, beating economist expectations. The Commerce Department found retailer sales rose 1.2 percent in August compared to half a percent decrease in July. July's lower-than-expected sales were attributed to Prime Day and related promotions shifting from July to June this year. and Danish drugmaker Novo Nordisk and Anthropic have announced a new partnership to accelerate the development of new medicines using Anthropic's CLAWD AI model. It's the latest partnership between the maker of Wigovi and an AI lab, following recent agreements with OpenAI and Amazon Web Services. Heads up, an artificial intelligence tool helped us make this episode by creating summaries that were based on WSJ reporting and then reviewed and adapted by an editor.
What is NICE’s CXAI platform and how does it improve customer experience?
And we have a lot more coverage on the WSJ's What's News. Listen and subscribe wherever you get your podcasts.
AI has opened infinite possibilities for customer experience and endless complexity because piloting AI tools is easy. Making them work together across a global enterprise is something else entirely. NICE is the CXAI platform that runs customer experience at scale, uniting agentic agents, human agents, and customer intelligence so the world's leading brands can move forward with confidence. NICE, the proven CXAI leader. Learn more at NICE.com.
No segments match your search.
Select any passage to copy it with its citation or turn it into a shareable card.
Chapters
6 chapters
1
What is the main topic discussed in this episode?
0:00–0:36
2
Why did Intel shares jump after reports of talks with SK Hynix?
0:36–0:56
3
What are the details of the potential Intel‑SK Hynix memory‑chip partnership?
0:56–1:08
4
How did U.S. retail sales perform in August and why did they rebound?
1:08–1:12
5
How are Novo Nordisk and Anthropic using Claude AI to speed drug discovery?
1:12–1:53
6
What is NICE’s CXAI platform and how does it improve customer experience?
1:53–2:30